SpaceX Files for Stock Market Debut Ticker Could Be SPCX Potential to Make Elon Musk a Trillionaire Indian Stock Markets Surge on USIran Peace Deal Hopes Sensex Jumps 900 Points Nifty Approaches 24000 Professional Title AIDriven Hiring Doom Loop JobSeekers and Recruiters in an Arms Race of Homogenized Applications Zydus Lifesciences Revises Share Buyback Higher Price Lower Share Count Australian Taxpayer Subsidies and BHP Climate Retreat Raise Questions on Emission Goals Lam Research Corporation Rallies on Strong AIDriven Semiconductor Equipment Demand PFIS Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment MGY Q1 2026 Earnings EPS Beats Expectations as Operational Efficiency Drives Surprise ELF Q1 2026 Earnings EPS Beat Fails to Lift Stock as Market Digests Mixed Signals CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency CNMD Q1 2026 Earnings Adjusted EPS Surpasses Consensus Shares Edge Higher CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short Empire Petroleum EP Surges 776 as Momentum Builds Above Key Support Ernexa Therapeutics ERNA Slips 38 as Shares Test Key Support Near 1139 CCSC Technology CCTG Shows Modest Gains as Stock Hovers Near Resistance Navitas Semiconductor NVTS Surges Over 8 on Strong Volume Testing Key Resistance GigCapital7 Unit GIGGU Holds Steady at 994 as Market Digests SPAC Dynamics Nvidias Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Concession Backblaze Q1 2026 Earnings EPS Misses Estimates as Wider Loss Sends Mixed Signals Pampa Energia PAM Upticks 264 Testing Resistance at 8738 Nuveen New York Municipal Value Fund NNY Edges Higher Amid Steady Muni Demand B2Gold Corp BTG Gains Momentum With 354 Rally as Gold Sentiment Brightens BEPJ Edges Higher as Perpetual Preferred Note Shows Resilience at 2499 Autolus Therapeutics AUTL Advances 394 as Momentum Builds Toward Key Resistance LaFayette Acquisition Corp LAFA Holds Steady at 1009 as Support and Resistance Levels Define Trading Range Enphase Energy ENPH Surges 45 as Support Holds Testing Key Resistance Vistagen Therapeutics VTGN Holds Near Support After Minor Decline